Incyte (INCY) Revenue — Quarter Ended Sep 30, 2024
Revenue for the quarter increased compared to the prior quarter and was significantly higher than the same quarter one year earlier. The year-over-year growth was notably stronger than the sequential growth.
Key takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
Revenue for the quarter increased compared to the prior quarter and was significantly higher than the same quarter one year earlier. The year-over-year growth was notably stronger than the sequential growth.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.1B
Revenue reported for this quarter.
Quarter-over-quarter
+9.0%
Change from the immediately preceding quarter.
Year-over-year
+23.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $1B | +9.3% |
| Mar 31, 2024 | $880.9M | +8.9% |
| Jun 30, 2024 | $1B | +9.3% |
| Sep 30, 2024 | $1.1B | +23.8% |
Revenue performance
Revenue rose in the current quarter, extending the upward trajectory seen in recent periods.
Quarterly comparison
Sequentially, revenue advanced from the immediately preceding quarter. Compared with the same quarter a year ago, revenue posted a much larger increase, reflecting a stronger year-over-year performance.
What to watch
The filing describes a notice letter regarding a generic challenge to patents covering a key product, which could affect future revenue.